Patents by Inventor Christina Van Geen Hoven

Christina Van Geen Hoven has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOGENIC COMPOSITION AGAINST INFLUENZA
    Publication number: 20220362372
    Abstract: The invention relates to compositions and methods for the preparation, manufacture and therapeutic use ribonucleic acid vaccines comprising polynucleotide molecules encoding one or more influenza antigens, such as hemagglutinin antigens.
    Type: Application
    Filed: April 29, 2022
    Publication date: November 17, 2022
    Inventors: Philip Ralph Dormitzer, Advait Vijay Badkar, Christina Van Geen Hoven, Kathrin Ute Jansen, Pirada Suphaphiphat Allen, Ramin Darvari, Mark Duda
  • Therapeutic nanoparticles comprising a protonatable nitrogen therapeutic agent and methods of making and using same
    Patent number: 10583092
    Abstract: The present disclosure generally relates to nanoparticles comprising a substantially hydrophobic acid, a basic therapeutic agent having a protonatable nitrogen, and a polymer. Other aspects include methods of making and using such nanoparticles.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: March 10, 2020
    Assignee: Pfizer Inc.
    Inventors: Maria Figueiredo, Erick Peeke, David Dewitt, Christina Van Geen Hoven, Greg Troiano, James Wright, Yong-ho Song, Hong Wang
  • THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING SAME
    Publication number: 20190111004
    Abstract: The present disclosure generally relates to nanoparticles comprising a substantially hydrophobic acid, a basic therapeutic agent having a protonatable nitrogen, and a polymer. Other aspects include methods of making and using such nanoparticles.
    Type: Application
    Filed: September 7, 2018
    Publication date: April 18, 2019
    Applicant: Pfizer Inc.
    Inventors: Maria Figueiredo, Erick Peeke, David Dewitt, Christina Van Geen Hoven, Greg Troiano, James Wright, Yong-ho Song, Hong Wang
  • Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
    Patent number: 10080723
    Abstract: The present disclosure generally relates to nanoparticles comprising a substantially hydrophobic acid, a basic therapeutic agent having a protonatable nitrogen, and a polymer. Other aspects include methods of making and using such nanoparticles.
    Type: Grant
    Filed: February 13, 2015
    Date of Patent: September 25, 2018
    Assignee: Pfizer Inc.
    Inventors: Maria Figueiredo, Erick Peeke, David Dewitt, Christina Van Geen Hoven, Greg Troiano, James Wright, Young-ho Song, Hong Wang
  • Process for preparing therapeutic nanoparticles
    Patent number: 9877923
    Abstract: The present disclosure generally relates to a process for preparing therapeutic nanoparticles, where the process includes combining a therapeutic agent with an organic acid. The therapeutic nanoparticles may have, for example, improved drug loading and/or drug release properties.
    Type: Grant
    Filed: September 16, 2013
    Date of Patent: January 30, 2018
    Assignee: Pfizer Inc.
    Inventors: Maria Figueiredo, Erick Peeke, David Dewitt, Christina Van Geen Hoven, Greg Troiano, James Wright, Young-Ho Song, Hong Wang
  • Stable formulations for lyophilizing therapeutic particles
    Patent number: 9872848
    Abstract: The present disclosure generally relates to lyophilized pharmaceutical compositions comprising polymeric nanoparticles which, upon reconstitution, have low levels of greater than 10 micron size particles. Other aspects of the invention include methods of making such nanoparticles.
    Type: Grant
    Filed: October 18, 2016
    Date of Patent: January 23, 2018
    Assignee: Pfizer Inc.
    Inventors: Greg Troiano, Young-ho Song, Stephen E. Zale, James Wright, Christina Van Geen Hoven
  • STABLE FORMULATIONS FOR LYOPHILIZING THERAPEUTIC PARTICLES
    Publication number: 20170189368
    Abstract: The present disclosure generally relates to lyophilized pharmaceutical compositions comprising polymeric nanoparticles which, upon reconstitution, have low levels of greater than 10 micron size particles. Other aspects of the invention include methods of making such nanoparticles.
    Type: Application
    Filed: October 18, 2016
    Publication date: July 6, 2017
    Inventors: Greg Troiano, Young-ho Song, Stephen E. Zale, James Wright, Christina Van Geen Hoven
  • Therapeutic Nanoparticles Comprising A Therapeutic Agent And Methods Of Making And Using Same
    Publication number: 20170119672
    Abstract: The present disclosure generally relates to nanoparticles comprising a substantially hydrophobic acid, a basic therapeutic agent having a protonatable nitrogen, and a polymer. Other aspects include methods of making and using such nanoparticles.
    Type: Application
    Filed: January 13, 2017
    Publication date: May 4, 2017
    Applicant: Pfizer Inc.
    Inventors: Maria Figueiredo, Erick Peeke, David Dewitt, Christina Van Geen Hoven, Greg Troiano, James Wright, Young-Ho Song, Hong Wang
  • THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING SAME
    Publication number: 20170042828
    Abstract: The present disclosure generally relates to nanoparticles comprising a substantially hydrophobic acid, a basic therapeutic agent having a protonatable nitrogen, and a polymer. Other aspects include methods of making and using such nanoparticles.
    Type: Application
    Filed: February 13, 2015
    Publication date: February 16, 2017
    Inventors: Maria Figueiredo, Erick Peeke, David Dewitt, Christina Van Geen Hoven, Greg Troiano, James Wright, Young-ho Song, Hong Wang
  • Stable formulations for lyophilizing therapeutic particles
    Patent number: 9498443
    Abstract: The present disclosure generally relates to lyophilized pharmaceutical compositions comprising a sugar, a cyclodextrin, and polymeric nanoparticles comprising a copolymer and a therapeutic agent which, upon reconstitution, have low levels of greater than 10 micron size particles. Other aspects of the invention include methods of making such nanoparticles.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: November 22, 2016
    Assignee: Pfizer Inc.
    Inventors: Greg Troiano, Young-Ho Song, Stephen E. Zale, James Wright, Christina Van Geen Hoven
  • Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
    Patent number: 9295649
    Abstract: The present disclosure relates in part to pharmaceutical compositions comprising polymeric nanoparticles having certain glass transition temperatures. Other aspects of the invention include methods of making such nanoparticles.
    Type: Grant
    Filed: December 15, 2010
    Date of Patent: March 29, 2016
    Assignee: BIND Therapeutics, Inc.
    Inventors: Mir Mukkaram Ali, Abhimanyu Sabnis, David Dewitt, Greg Troiano, James Wright, Maria Figueiredo, Michael Figa, Christina Van Geen Hoven, Young-Ho Song, Jason Auer, Tarikh Christopher Campbell
  • STABLE FORMULATIONS FOR LYOPHILIZING THERAPEUTIC PARTICLES
    Publication number: 20150283081
    Abstract: The present disclosure generally relates to lyophilized pharmaceutical compositions comprising polymeric nanoparticles which, upon reconstitution, have low levels of greater than 10 micron size particles. Other aspects of the invention include methods of making such nanoparticles.
    Type: Application
    Filed: November 7, 2014
    Publication date: October 8, 2015
    Inventors: Greg Troiano, Young-Ho Song, Stephen E. Zale, James Wright, Christina Van Geen Hoven
  • Stable formulations for lyophilizing therapeutic particles
    Patent number: 8956657
    Abstract: The present disclosure generally relates to lyophilized pharmaceutical compositions comprising polymeric nanoparticles which, upon reconstitution, have low levels of greater than 10 micron size particles. Other aspects of the invention include methods of making such nanoparticles.
    Type: Grant
    Filed: April 12, 2013
    Date of Patent: February 17, 2015
    Assignee: BIND Therapeutics, Inc.
    Inventors: Greg Troiano, Young-Ho Song, Stephen E. Zale, James Wright, Christina Van Geen Hoven
  • Stable formulations for lyophilizing therapeutic particles
    Patent number: 8916203
    Abstract: The present disclosure generally relates to lyophilized pharmaceutical compositions comprising polymeric nanoparticles which, upon reconstitution, have low levels of greater than 10 micron size particles. Other aspects of the invention include methods of making such nanoparticles.
    Type: Grant
    Filed: October 30, 2012
    Date of Patent: December 23, 2014
    Assignee: BIND Therapeutics, Inc.
    Inventors: Greg Troiano, Young-Ho Song, Stephen E. Zale, James Wright, Christina Van Geen Hoven
  • Therapeutic Nanoparticles Comprising a Therapeutic Agent and Methods of Making and Using Same
    Publication number: 20140249158
    Abstract: The present disclosure generally relates to nanoparticles comprising a substantially hydrophobic acid, a basic therapeutic agent having a protonatable nitrogen, and a polymer. Other aspects include methods of making and using such nanoparticles.
    Type: Application
    Filed: May 13, 2014
    Publication date: September 4, 2014
    Applicant: BIND Therapeutics, Inc.
    Inventors: Maria Figueiredo, Erick Peeke, David Dewitt, Christina Van Geen Hoven, Greg Troiano, James Wright, Young-Ho Song, Hong Wang
  • Therapeutic Nanoparticles Comprising a Therapeutic Agent and Methods of Making and Using Same
    Publication number: 20140248358
    Abstract: The present disclosure generally relates to nanoparticles comprising a substantially hydrophobic acid, a basic therapeutic agent having a protonatable nitrogen, and a polymer. Other aspects include methods of making and using such nanoparticles.
    Type: Application
    Filed: May 13, 2014
    Publication date: September 4, 2014
    Applicant: BIND Therapeutics, Inc.
    Inventors: Maria Figueiredo, Erick Peeke, David Dewitt, Christina Van Geen Hoven, Greg Troiano, James Wright, Young-Ho Song, Hong Wang
  • Process for Preparing Therapeutic Nanoparticles
    Publication number: 20140186452
    Abstract: The present disclosure generally relates to a process for preparing therapeutic nanoparticles, where the process includes combining a therapeutic agent with an organic acid. The therapeutic nanoparticles may have, for example, improved drug loading and/or drug release properties.
    Type: Application
    Filed: September 16, 2013
    Publication date: July 3, 2014
    Applicant: BIND THERAPEUTICS, INC.
    Inventors: Maria Figueiredo, Erick Peeke, David Dewitt, Christina Van Geen Hoven, Greg Troiano, James Wright, Young-Ho Song, Hong Wang
  • Therapeutic Nanoparticles Comprising a Therapeutic Agent and Methods of Making and Using Same
    Publication number: 20140178475
    Abstract: The present disclosure generally relates to nanoparticles comprising a substantially hydrophobic acid, a basic therapeutic agent having a protonatable nitrogen, and a polymer. Other aspects include methods of making and using such nanoparticles.
    Type: Application
    Filed: September 16, 2013
    Publication date: June 26, 2014
    Applicant: BIND Therapeutics, Inc.
    Inventors: Maria Figueiredo, Erick Peeke, David Dewitt, Christina Van Geen Hoven, Greg Troiano, James Wright, Young-Ho Song, Hong Wang
  • Stable formulations for lyophilizing therapeutic particles
    Patent number: 8637083
    Abstract: The present disclosure generally relates to lyophilized pharmaceutical compositions comprising polymeric nanoparticles which, upon reconstitution, have low levels of greater than 10 micron size particles. Other aspects of the invention include methods of making such nanoparticles.
    Type: Grant
    Filed: June 12, 2013
    Date of Patent: January 28, 2014
    Assignee: BIND Therapeutics, Inc.
    Inventors: Greg Troiano, Young-Ho Song, Stephen E. Zale, James Wright, Christina Van Geen Hoven
  • Stable formulations for lyophilizing therapeutic particles
    Patent number: 8603535
    Abstract: The present disclosure generally relates to lyophilized pharmaceutical compositions comprising polymeric nanoparticles which, upon reconstitution, have low levels of greater than 10 micron size particles. Other aspects of the invention include methods of making such nanoparticles.
    Type: Grant
    Filed: June 4, 2013
    Date of Patent: December 10, 2013
    Assignee: BIND Therapeutics, Inc.
    Inventors: Greg Troiano, Young-Ho Song, Stephen E. Zale, James Wright, Christina Van Geen Hoven